Short CommunicationThe unexpected identification of the cannabimimetic, 5F-ADB, and DEXTROMETHORPHAN (cas 125-71-3) in commercially available cannabidiol e-liquids

Add time:09/26/2019    Source:sciencedirect.com

Electronic cigarettes (e-cigarettes) were developed as an alternative method for nicotine delivery and had a significant surge in popularity. E-liquids are formulations used in e-cigarettes, and consist of a ratio of propylene glycol (PG) and vegetable glycerin (VG), a pharmaceutical and/or herbal remedy and, usually, a flavoring agent. Presented is the evaluation of nine cannabidiol (CBD) e-liquids from a single manufacturer for cannabinoids and other psychoactive compounds by Direct Analysis in Real Time Mass Spectrometry (DART-MS) and Gas Chromatography Mass Spectrometry (GC/MS). The analysis of these products resulted in the detection of CBD in all nine produces and the unexpected detections of 5-fluoro MDMB-PINACA (5F-ADB) in four of the products and DEXTROMETHORPHAN (cas 125-71-3) (DXM) in one of the products. The analysis of these products illustrates the potential quality control issues that can occur in an unregulated industry. CBD products are believed by many users to offer heath benefits, but the detection of a dangerous cannabimimetic, 5F-ADB, and DXM in these products illustrates the need for oversight.

We also recommend Trading Suppliers and Manufacturers of DEXTROMETHORPHAN (cas 125-71-3). Pls Click Website Link as below: cas 125-71-3 suppliers

Prev:Research reportThe blockade of 5-HT1A receptors in the ventral tegmental area inhibited morphine/DEXTROMETHORPHAN (cas 125-71-3)-induced analgesia in pain rat models
Next:Research reportUnidirectional analgesic cross-tolerance between morphine and levorphanol in the rat)